Back to Results
First PageMeta Content
Lymphoma / Histone deacetylase inhibitor / Cutaneous T-cell lymphoma / Romidepsin / Vorinostat / Histone deacetylase / Merck & Co. / Mesothelioma / Targeted therapy / Medicine / Pharmacology / Orphan drugs


Mesothelioma Articles - Merck & Co: Zolinza becomes first app...
Add to Reading List

Document Date: 2010-10-19 13:01:20

Open Document

File Size: 39,24 KB

Share Result on Facebook
UPDATE